SALT
LAKE CITY, Aug. 31, 2022 /PRNewswire/
-- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"
or Co-Dx), a molecular diagnostics company with a unique, patented
platform for the development of molecular diagnostic tests,
announced today that it will be hosting a booth at the upcoming
Medical Fair Asia 2022 trade show held August 31-September 2 at the Marina Bay Sands in
Singapore.
Southeast Asia's most
established trade fair for the medical and healthcare industry is
expected to host over 14,000 visitors from 70 counties and regions,
and is open to medical specialists, business executives in the
medical trade and other relevant professionals involved in the
industry. The Company expects that the show will provide
opportunities for Company representatives and distributors to
introduce Co-Diagnostics products to a wide array of international
customers, and to strengthen the Company's distributor outreach
across Asia.
To learn more about the conference, including in-person and
virtual registration details, please visit
www.medicalfair-asia.com. Attendees interested in learning more
about the Company and its products, including its upcoming
point-of-care and at-home rapid PCR diagnostics platform, are
invited to visit Booth #2G01.
About Co-Diagnostics,
Inc.:
Co-Diagnostics, Inc., a Utah
corporation, is a molecular diagnostics company that develops,
manufactures and markets state-of-the-art diagnostics technologies.
The Company's technology is utilized for tests that are designed
using the detection and/or analysis of nucleic acid molecules (DNA
or RNA). The Company also uses its proprietary technology to design
specific tests to locate genetic markers for use in industries
other than infectious disease and license the use of those tests to
specific customers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medical-fair-asia-2022-in-singapore-on-aug-31-sep-2-301615368.html
SOURCE Co-Diagnostics